FindTrial
Sign In

Comparison of two local anesthetics for spinal anesthesia in caesarean section

Comparison of Clinical Efficacy and Safety Profile of Hyperbaric Ropivacaine 0.75% and Hyperbaric Bupivacaine 0.5% in Spinal Anesthesia for Patients Posted for Elective Caesarean Section: An Observational Study in A Tertiary Care Hospital in Mandya. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061890
Enrollment
80
Registered
2024-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: Ropivacaine 0.75% 2 ml: Clinical efficacy and safety profile if ropivacaine 0.75% 2 cc in elective caesarean section. Control Intervention1: Bupivacaine 0.5% 2 ml: Clinical efficacy and

Sponsors

Dr Shivakumar G
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for elective caesarean section surgeries. Age group 18 to 40 years. Patients with height 150cm-180cm and weight 40kg-80kg. Patients with American Society of Anaesthesiologists-Physical status (ASA-PS) grade I and II. Patients willing to give informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Patients with cardiovascular diseases or pregnancy induced hypertension and gestational diabetes mellitus. Patients having increased intracranial tension, severe hypovolemia, history of bleeding diathesis and local infection.

Design outcomes

Primary

MeasureTime frame
Comparing the onset and duration of sensory and motor blockade.Timepoint: 24 hours—

Secondary

MeasureTime frame
To compare the anaesthetic profile and effects of intrathecal hyperbaric ropivacaine 0.75% and hyperbaric bupivacaine 0.5% in spinal anaesthesia for elective caesarean section by using the following parameters: 1.Intraoperative hemodynamic parameters. 2.Duration of analgesia (until first dose of analgesia demand). 3.Adverse effects. Timepoint: UPTO 24 HOURS—

Countries

India

Contacts

Public ContactDr Shivakumar G

MANDYA INSTITUTE OF MEDICAL SCIENCES

dranashiv@gmail.com9900468451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026